Da-Tian Bau Selected Research

benzyloxycarbonyl- isoleucyl- glutamyl(O- tert- butyl)- alanyl- leucinal

9/2019

Proteasome Inhibitors Suppress ErbB Family Expression through HSP90-Mediated Lysosomal Degradation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Da-Tian Bau Research Topics

Disease

64	Neoplasms (Cancer) 01/2022 - 12/2003
33	Carcinogenesis 11/2021 - 09/2008
27	Mouth Neoplasms (Oral Cancer) 01/2021 - 05/2007
20	Breast Neoplasms (Breast Cancer) 03/2021 - 07/2004
14	Lung Neoplasms (Lung Cancer) 09/2019 - 11/2009
11	Genomic Instability 01/2016 - 08/2007
9	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 07/2007
9	Leukemia 03/2021 - 02/2010
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 08/2014
7	Urinary Bladder Neoplasms (Bladder Cancer) 11/2021 - 10/2009
7	Stomach Neoplasms (Stomach Cancer) 06/2017 - 02/2008
6	Nasopharyngeal Carcinoma 01/2018 - 10/2011
6	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 02/2012
6	Endometriosis 11/2014 - 12/2007
5	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2011
4	Hypertension (High Blood Pressure) 01/2020 - 01/2015
4	Leiomyoma (Uterine Fibroids) 11/2019 - 10/2008
4	Inflammation (Inflammations) 01/2017 - 12/2003
4	Carcinoma (Carcinomatosis) 05/2015 - 09/2012
3	Genetic Risk Score 01/2022 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2010
3	Asthma (Bronchial Asthma) 01/2017 - 01/2015
3	Triple Negative Breast Neoplasms 03/2016 - 01/2014
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016 - 09/2010
3	Hypoxia (Hypoxemia) 04/2013 - 04/2008
3	Pterygium 04/2010 - 08/2007
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 09/2012
2	Chronic Renal Insufficiency 01/2021 - 05/2008
2	Infections 01/2021 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 12/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 12/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2019 - 02/2012
2	Body Weight (Weight, Body) 05/2018 - 10/2010
2	Acute Promyelocytic Leukemia 01/2017 - 09/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 11/2012
2	Obesity 12/2012 - 04/2008
2	Xeroderma Pigmentosum (Kaposi's Disease) 04/2010 - 10/2008

Drug/Important Bio-Agent (IBA)

28	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2004
26	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2007
20	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2011
20	Codon (Codons)IBA 09/2015 - 05/2007
12	Caveolin 1IBA 08/2014 - 08/2010
9	CytokinesIBA 03/2019 - 08/2013
8	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2014 - 04/2010
7	Pharmaceutical PreparationsIBA 01/2021 - 11/2008
6	Insulin (Novolin)FDA Link 01/2022 - 12/2012
6	Cyclin D1IBA 08/2015 - 01/2011
5	8-hydroxyguanineIBA 01/2020 - 03/2009
5	Arecoline (Arecolin)IBA 01/2019 - 09/2010
5	Interleukin-10 (Interleukin 10)IBA 11/2015 - 08/2013
5	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2015 - 11/2009
4	Insulin-Like Growth Factor Binding Protein 3IBA 01/2022 - 01/2021
4	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 01/2021
4	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 04/2013
4	Hormones (Hormone)IBA 11/2019 - 01/2012
4	Caspase 3 (Caspase-3)IBA 05/2018 - 04/2008
4	Biological ProductsIBA 01/2018 - 01/2015
3	Insulin-Like PeptidesIBA 11/2021 - 01/2021
3	DiarylheptanoidsIBA 07/2021 - 01/2018
3	Antineoplastic Agents (Antineoplastics)IBA 05/2018 - 01/2015
3	P-2 (P 2)IBA 12/2014 - 03/2012
3	RNA (Ribonucleic Acid)IBA 11/2014 - 02/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013 - 04/2008
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 02/2013 - 08/2007
3	arginylarginine (Arg-Arg)IBA 12/2011 - 05/2007
2	Carrier Proteins (Binding Protein)IBA 01/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2021
2	EndonucleasesIBA 01/2020 - 11/2014
2	Messenger RNA (mRNA)IBA 01/2020 - 11/2014
2	Interleukin-18 (Interleukin 18)IBA 03/2019 - 01/2018
2	Acridine OrangeIBA 05/2018 - 01/2018
2	CurcuminIBA 05/2018 - 01/2018
2	bisdemethoxycurcuminIBA 05/2018 - 01/2018
2	Dithiothreitol (Cleland's Reagent)IBA 01/2017 - 09/2010
2	Arsenic Trioxide (Trisenox)FDA Link 01/2017 - 09/2010
2	CarcinogensIBA 01/2017 - 12/2007
2	taiwanin CIBA 01/2017 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 12/2012
2	ArsenicIBA 01/2017 - 12/2003
2	NF-kappa B (NF-kB)IBA 12/2016 - 10/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016 - 10/2015
2	Metalloproteases (Metalloproteinases)IBA 03/2016 - 01/2016
2	Tissue Inhibitor of Metalloproteinase-1IBA 03/2016 - 01/2016
2	X-ray repair cross complementing protein 3IBA 09/2015 - 06/2014
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2015 - 10/2014
2	FlavonoidsIBA 01/2015 - 02/2012
2	Interferon-gamma (Interferon, gamma)IBA 07/2014 - 08/2013
2	NucleotidesIBA 11/2013 - 10/2011
2	Photosensitizing Agents (Photosensitizers)IBA 09/2012 - 12/2010
2	aloe emodinIBA 09/2012 - 12/2010
2	Caspase 8 (Caspase-8)IBA 02/2012 - 04/2008
2	prolyl-proline (Pro-Pro)IBA 12/2011 - 05/2007
2	alpha-Crystallin B ChainIBA 09/2011 - 01/2011
2	DNA Glycosylases (DNA Glycosylase)IBA 10/2010 - 04/2010
2	exodeoxyribonuclease IIBA 12/2009 - 09/2009
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 06/2009 - 04/2008

Therapy/Procedure

11	Therapeutics 01/2021 - 09/2010
3	Radiotherapy 03/2021 - 01/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2017 - 10/2016
2	Precision Medicine 12/2013 - 12/2011